§826. Production quotas for controlled substances — Inbound Citations
21 U.S.C. § 826
Cited by 8 provisions in release 119-102.
Citations to 21 U.S.C. § 826 as a whole
-
(1) determine whether the notification pertains to a controlled substance subject to a production quota under section 826 of this title; and
-
(B) request that the Attorney General increase the aggregate and individual production quotas under section 826 of this title applicable to such controlled substance and any ingredient therein to a level the Secretary deems necessary to address a shortage of a controlled substance based on the best available market data; and
-
(d) Registration granted under subsections (a) and (b) of this section shall not entitle a registrant to (1) manufacture or distribute controlled substances in schedule I or II other than those specified in the registration, or (2) manufacture any quantity of those controlled substances in excess of the quota assigned pursuant to section 826 of this title.
-
(e) The suspension or revocation of a registration under this section shall operate to suspend or revoke any quota applicable under section 826 of this title.
-
(3) identifies drugs containing a controlled substance subject to section 826 of this title when such a drug is determined by the Secretary to be in shortage.
-
(1) not expressly authorized by his registration and by a quota assigned to him pursuant to section 826 of this title; or
-
(2) in excess of a quota assigned to him pursuant to section 826 of this title.
Citations to §826(h)
-
(1) identifies the number of requests received under section 826(h) of this title (as added by section 1005 of this Act), the average review time for such requests, the number of requests granted and denied under such section, and, for each of the requests denied under such section, the basis for such denial;